PINK COPYRIGHT: A GROWING DANGER?

A alarming trend is emerging within the drug scene: "Pink copyright," formally known as Flunitramadol. This synthetic opioid is being marketed as a crystal , often presented as copyright, posing a significant risk to people. Its seemingly low price and convenient accessibility are contributing it